Table 5.

Comparison of IES-R, STAI-S and STAI-T Scores Between IBD Patients According to Treatment Characteristics

	Treatment Modality I				Treatment Modality II
Intravenous (n = 127)	Subcutaneous (n = 72)	t	P	Oral (n = 295)	Intravenous + Subcutaneous (n = 199)	t	P
IES-R total (mean ± SD)	22.90 ± 12.67	24.51 ± 12.69	−0.86	.389	24.18 ± 15.88	23.48 ± 12.67	0.52	.603
Intrusion (mean ± SD)	6.76 ± 5.07	7.28 ± 5.74	−0.67	.507	7.56 ± 6.52	6.94 ± 5.31	1.10	.272
Avoidance (mean ± SD)	11.12 ± 5.58	11.76 ± 4.24	−0.85	.35	10.81 ± 5.54	11.35 ± 5.13	−1.10	.273
Hyperarousal (mean ± SD)	5.02 ± 4.38	5.47 ± 4.68	−0.68	.499	5.82 ± 5.66	5.19 ± 4.49	1.32	.188
STAI-S	40.02 ± 11.31	38.68 ± 11.55	0.79	.428	39.41 ± 12.27	39.53 ± 11.38	−0.12	.908
STAI-T	44.50 ± 10.37	45.63 ± 9.96	−0.74	.458	44.25 ± 11.58	44.91 ± 10.21	−0.65	.518